Absorbable Coronary Drug-Eluting Stent
The Absorbable Coronary Drug-Eluting Stent (product code PNY) is a Class 3 cardiovascular device consisting of an absorbable scaffold with a drug coating placed via a delivery catheter into the coronary artery or saphenous vein graft to maintain the lumen; the drug coating is intended to inhibit restenosis. Class 3 classification requires Premarket Approval (PMA). The device is flagged as both an implant and a life-sustaining/life-supporting device, and no regulation number has been formally assigned.
Basic Information
- Product Code
- PNY
- Device Class
- FDA class 3
- Medical Specialty
- Unknown
- Review Panel
- CV
- Submission Type
- 2
Device Characteristics
Definition
An absorbable scaffold with a drug coating placed via a delivery catheter into the coronary artery or saphenous vein graft to maintain the lumen. The drug coating is intended to inhibit restenosis.
FEI Numbers
This FDA classification entry is associated with 3 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 3 registration numbers. Click on an entry to view related FDA registrations.